This evidence gap means prescribers must exercise clinical judgement when considering these treatments
ISBN 0-395-98272-3
The difference between GLP-1 patches and injections While GLP-1 patches present an appealing concept, substantial differences exist between these patches and FDA-approved GLP-1 injections regarding their composition , delivery mechanism , and proven effectiveness
Relevant clinical diseases Neurodegenerative diseases Generally, neurodegenerative diseases (NDDs) exhibit multiple and common pathological effects, including defects in mitochondria, protein quality control, and the autophagic-lysosomal network, which lead to the aggregation and accumulation of misfolded proteins [173, 174]
Of particular note is ferroptosis, a novel form of programmed cell death, which plays a pivotal role in the pathological process of IBD
Who Short-Term GLP-1 Use Might Suit Short-term use may be appropriate for people who are relatively close to their goal weight and need a modest, defined intervention
